DOTSON JERROLD DUANE
Insider CIK 1388853 · VSTA VP, CFO AND SECRETARY
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN Vistagen Therapeutics, Inc | A Award | 2023-06-30 | 2023-07-05 | 167 | $1.59 | $266 | 3,671 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2022-12-30 | 2023-01-03 | 5,000 | $0.09 | $450 | 105,111 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2022-07-30 | 2022-07-15 | 5,000 | $0.75 | $3.8K | 100,111 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2022-01-11 | 2022-01-12 | 18,750 | — | $0 | 15,625 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2022-01-11 | 2022-01-12 | 18,750 | $1.00 | $18.8K | 94,571 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2021-12-31 | 2022-01-03 | 3,575 | $1.66 | $5.9K | 75,821 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | S Sale | 2021-09-07 | 2021-09-08 | 30,000 | $3.13 | $93.9K | 72,786 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2021-06-30 | 2021-07-02 | 78,918 | — | $0 | 34,375 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2021-06-30 | 2021-07-02 | 9,824 | — | $0 | 140,176 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2021-06-30 | 2021-07-02 | 36,707 | — | $0 | 113,293 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2021-06-30 | 2021-07-02 | 1,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2021-06-30 | 2021-07-02 | 3,044 | $1.95 | $5.9K | 13,044 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2021-06-30 | 2021-07-02 | 1,000 | $1.50 | $1.5K | 14,044 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2021-06-30 | 2021-07-02 | 78,918 | $1.00 | $78.9K | 92,962 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2021-06-30 | 2021-07-02 | 9,824 | $0.40 | $3.9K | 102,786 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2020-12-31 | 2021-01-04 | 5,000 | $0.45 | $2.3K | 10,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-12-30 | 2021-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2020-06-30 | 2020-07-01 | 5,000 | $0.45 | $2.3K | 5,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-04-23 | 2020-04-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-10-21 | 2019-10-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-23 | 2019-05-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 75,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 678 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 100,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 50,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 1,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 4,323 | — | $0 | 4,323 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 4,323 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 678 | — | $0 | 678 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-05 | 2018-08-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-02-02 | 2018-02-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-09-19 | 2017-09-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-04-26 | 2017-04-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-11-09 | 2016-11-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-06-19 | 2016-06-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 100,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 10,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 5,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-09-02 | 2015-09-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-01-11 | 2015-01-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2014-03-19 | 2014-03-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 13,541 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 6,251 | — | $0 | 6,251 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 86,459 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 6,251 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 86,459 | — | $0 | 86,459 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 6,249 | — | $0 | 6,249 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 13,541 | — | $0 | 13,541 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 6,249 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 1,000 | — | $0 | 1,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 1,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-10-27 | 2013-10-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2013-03-03 | 2013-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2012-10-30 | 2012-11-01 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2012-10-30 | 2012-11-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2012-10-30 | 2012-11-01 | 2,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2012-10-30 | 2012-11-01 | 10,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2012-10-30 | 2012-11-01 | 12,500 | — | $0 | 12,500 | SEC↗ |